2023, Number 2
<< Back
Medicina & Laboratorio 2023; 27 (2)
von Willebrand factor antigen (VWF:Ag)
Vizcaíno-Carruyo JC, Pérez-Monterrosa ME, Toro-Montoya AI, Franco-Alzate C
Language: Spanish
References: 8
Page: 175-182
PDF size: 148.38 Kb.
Text Extraction
No abstract.
REFERENCES
Ledford-Kraemer MR. Analysis of von Willebrandfactor structure by multimer analysis.Am J Hematol 2010;85:510-514. https://doi.org/10.1002/ajh.21739.
Ruggeri ZM. Von Willebrand factor. CurrOpin Hematol 2003;10:142-149. https://doi.org/10.1097/00062752-200303000-00008.
Fogarty H, Doherty D, O'Donnell JS. Newdevelopments in von Willebrand disease. BrJ Haematol 2020;191:329-339. https://doi.org/10.1111/bjh.16681.
Franchini M, Mannucci PM. Acquired von Willebrandsyndrome: focused for hematologists.Haematologica 2020;105:2032-2037. https://doi.org/10.3324/haematol.2020.255117.
Makris M, Hermans C. The 2021 von Willebranddisease guidelines: Clarity and controversy. Haemophilia 2022;28:1-3. https://doi.org/10.1111/hae.14465.
Baronciani L, Peyvandi F. How we make anaccurate diagnosis of von Willebrand disease.Thromb Res 2020;196:579-589. https://doi.org/10.1016/j.thromres.2019.07.010.
Bodó I, Eikenboom J, Montgomery R, PatzkeJ, Schneppenheim R, Di Paola J. Plateletdependentvon Willebrand factor activity. Nomenclatureand methodology: communicationfrom the SSC of the ISTH. J Thromb Haemost2015;13:1345-1350. https://doi.org/10.1111/jth.12964.
Stockschlaeder M, Schneppenheim R,Budde U. Update on von Willebrand factormultimers: focus on high-molecular-weightmultimers and their role in hemostasis. BloodCoagul Fibrinolysis 2014;25:206-216. https://doi.org/10.1097/mbc.0000000000000065.
Full text